Log in to save to my catalogue

Relative Bioavailability Study of Midazolam Intramuscularly Administered with the Needle-Free Auto-I...

Relative Bioavailability Study of Midazolam Intramuscularly Administered with the Needle-Free Auto-I...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c60cd948732740d28a9db223e47ab4b5

Relative Bioavailability Study of Midazolam Intramuscularly Administered with the Needle-Free Auto-Injector ZENEO® in Healthy Adults

About this item

Full title

Relative Bioavailability Study of Midazolam Intramuscularly Administered with the Needle-Free Auto-Injector ZENEO® in Healthy Adults

Publisher

Cheshire: Springer Healthcare

Journal title

Neurology and therapy, 2024-08, Vol.13 (4), p.1155-1172

Language

English

Formats

Publication information

Publisher

Cheshire: Springer Healthcare

More information

Scope and Contents

Contents

Introduction
Intramuscular (IM) midazolam is indicated for the treatment of status epilepticus. Administration must be efficient to rapidly terminate prolonged seizures and prevent complications. The objective of this study was to compare, in terms of relative bioavailability and bioequivalence, IM midazolam injection by needle-free auto-injecto...

Alternative Titles

Full title

Relative Bioavailability Study of Midazolam Intramuscularly Administered with the Needle-Free Auto-Injector ZENEO® in Healthy Adults

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c60cd948732740d28a9db223e47ab4b5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c60cd948732740d28a9db223e47ab4b5

Other Identifiers

ISSN

2193-8253

E-ISSN

2193-6536

DOI

10.1007/s40120-024-00627-4

How to access this item